Clinical

Dataset Information

0

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC


ABSTRACT: The study evaluates the efficacy and safety of two strengths of LUT014 Gel topically applied once a day for 4 weeks, compared to placebo, in metastatic colorectal cancer (mCRC) patients who developed Grade 2 or non-infected Grade 3 EGFRI induced acneiform lesions

DISEASE(S): Egfri Induced Acneiform Lesions

PROVIDER: 2367764 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2299887 | ecrin-mdr-crc
2024-09-12 | PXD043034 | Pride
| 2565376 | ecrin-mdr-crc
| 2740781 | ecrin-mdr-crc
2017-01-12 | GSE90075 | GEO
2017-01-12 | GSE90071 | GEO
2008-06-01 | GSE10174 | GEO
| PRJNA1049973 | ENA
| PRJNA1049974 | ENA
2023-05-07 | GSE167858 | GEO